Taysha Gene Therapies, Inc. (TSHA) Net income 2020–2025
Taysha Gene Therapies, Inc. (TSHA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$109.0MFY2025 · since FY2020: -$60.0M → -$109.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$109.0M | -22.1% |
| FY2024 | -$89.3M | +20.0% |
| FY2023 | -$111.6M | +32.8% |
| FY2022 | -$166.0M | +4.9% |
| FY2021 | -$174.5M | -190.8% |
| FY2020 | -$60.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice